Global and China Cancer Test Market 2020 by Company, Type and Application, Forecast to 2025
Market Overview
The global Cancer Test market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Cancer Test market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Cancer Test market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for revenue by Type and Application. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Type, Cancer Test market has been segmented into Laboratory Tests, Genetic Tests, Imaging, Endoscopy, etc.
Breakdown by Application, Cancer Test has been segmented into Bladder Cancer Test, Breast Cancer Test, Cervical Cancer Test, Colorectal (Colon) Cancer Test, Ovarian Cancer Test, Prostate Cancer Test, Liver Cancer Test, Flow Cytometry, Other Organ Specific Cancer Test, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cancer Test market presented in the report. This section sheds light on the sales growth of different regional and country-level Cancer Test markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cancer Test market.
For China, this report analyses the China market by players, Type and Application, for the period 2015-2025.
Competitive Landscape and Cancer Test Market Share Analysis
Cancer Test competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Cancer Test revenue generated, market share, headquarters, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cancer Test revenue and market share for each player covered in this report.
The major players covered in Cancer Test are: Abbott, CytoCore, Beckman Coulter, Radient Pharmaceuticals, Cepheid, BD Diagnostics, Gen-Probe, bioMerieux, BioCurex, DiagnoCure, Qiagen, Roche(Ventana Medical Systems), Genomic Health, Vermillion, Siemens Heathcare Diagnostics, Panacea Pharmaceuticals, QIAGEN Marseille (Earlier Ipsogen), Trovagene, Roche, Myriad Genetics, etc. Among other players domestic and global, Cancer Test market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Market segment by players, this report covers
Abbott
CytoCore
Beckman Coulter
Radient Pharmaceuticals
Cepheid
BD Diagnostics
Gen-Probe
bioMerieux
BioCurex
DiagnoCure
Qiagen
Roche(Ventana Medical Systems)
Genomic Health
Vermillion
Siemens Heathcare Diagnostics
Panacea Pharmaceuticals
QIAGEN Marseille (Earlier Ipsogen)
Trovagene
Roche
Myriad Genetics
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
MENA (Saudi Arabia, UAE, Turkey and South Africa)
Market segment by Type, covers:
Laboratory Tests
Genetic Tests
Imaging
Endoscopy
Market segment by Application, can be divided into
Bladder Cancer Test
Breast Cancer Test
Cervical Cancer Test
Colorectal (Colon) Cancer Test
Ovarian Cancer Test
Prostate Cancer Test
Liver Cancer Test
Flow Cytometry
Other Organ Specific Cancer Test
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Cancer Test
1.2 Classification of Cancer Test by Type
1.2.1 Overview: Global Cancer Test Revenue by Type: 2015 Versus 2019 Versus 2025
1.2.2 Global Cancer Test Revenue Market Share by Type in 2019
1.2.3 Laboratory Tests
1.2.4 Genetic Tests
1.2.5 Imaging
1.2.6 Endoscopy
1.3 Global Cancer Test Market by Application
1.3.1 Overview: Global Cancer Test Revenue by Application: 2015 Versus 2019 Versus 2025
1.3.2 Bladder Cancer Test
1.3.3 Breast Cancer Test
1.3.4 Cervical Cancer Test
1.3.5 Colorectal (Colon) Cancer Test
1.3.6 Ovarian Cancer Test
1.3.7 Prostate Cancer Test
1.3.8 Liver Cancer Test
1.3.9 Flow Cytometry
1.3.10 Other Organ Specific Cancer Test
1.4 Global Cancer Test Market Size and Forecast (2015-2025)
1.5 Global Cancer Test Market Size by Regions: 2015 VS 2019 VS 2025
1.6 Global Cancer Test Market Size by Regions (2015-2020)
1.7 Global Cancer Test Market Size and Forecast by Regions (2020-2025)
1.7.1 North America Cancer Test Status and Prospect (2015-2025)
1.7.2 Europe Cancer Test Status and Prospect (2015-2025)
1.7.3 Asia Cancer Test Status and Prospect (2015-2025)
1.7.4 South America Cancer Test Status and Prospect (2015-2025)
1.7.5 Middle East & Africa Cancer Test Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott SWOT Analysis
2.1.4 Abbott Product and Services
2.1.5 Abbott Cancer Test Revenue, Gross Margin and Market Share (2018-2019)
2.2 CytoCore
2.2.1 CytoCore Details
2.2.2 CytoCore Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 CytoCore SWOT Analysis
2.2.4 CytoCore Product and Services
2.2.5 CytoCore Cancer Test Revenue, Gross Margin and Market Share (2018-2019)
2.3 Beckman Coulter
2.3.1 Beckman Coulter Details
2.3.2 Beckman Coulter Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Beckman Coulter SWOT Analysis
2.3.4 Beckman Coulter Product and Services
2.3.5 Beckman Coulter Cancer Test Revenue, Gross Margin and Market Share (2018-2019)
2.4 Radient Pharmaceuticals
2.4.1 Radient Pharmaceuticals Details
2.4.2 Radient Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Radient Pharmaceuticals SWOT Analysis
2.4.4 Radient Pharmaceuticals Product and Services
2.4.5 Radient Pharmaceuticals Cancer Test Revenue, Gross Margin and Market Share (2018-2019)
2.5 Cepheid
2.5.1 Cepheid Details
2.5.2 Cepheid Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Cepheid SWOT Analysis
2.5.4 Cepheid Product and Services
2.5.5 Cepheid Cancer Test Revenue, Gross Margin and Market Share (2018-2019)
2.6 BD Diagnostics
2.6.1 BD Diagnostics Details
2.6.2 BD Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 BD Diagnostics SWOT Analysis
2.6.4 BD Diagnostics Product and Services
2.6.5 BD Diagnostics Cancer Test Revenue, Gross Margin and Market Share (2018-2019)
2.7 Gen-Probe
2.7.1 Gen-Probe Details
2.7.2 Gen-Probe Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Gen-Probe SWOT Analysis
2.7.4 Gen-Probe Product and Services
2.7.5 Gen-Probe Cancer Test Revenue, Gross Margin and Market Share (2018-2019)
2.8 bioMerieux
2.8.1 bioMerieux Details
2.8.2 bioMerieux Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 bioMerieux SWOT Analysis
2.8.4 bioMerieux Product and Services
2.8.5 bioMerieux Cancer Test Revenue, Gross Margin and Market Share (2018-2019)
2.9 BioCurex
2.9.1 BioCurex Details
2.9.2 BioCurex Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 BioCurex SWOT Analysis
2.9.4 BioCurex Product and Services
2.9.5 BioCurex Cancer Test Revenue, Gross Margin and Market Share (2018-2019)
2.10 DiagnoCure
2.10.1 DiagnoCure Details
2.10.2 DiagnoCure Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 DiagnoCure SWOT Analysis
2.10.4 DiagnoCure Product and Services
2.10.5 DiagnoCure Cancer Test Revenue, Gross Margin and Market Share (2018-2019)
2.11 Qiagen
2.11.1 Qiagen Details
2.11.2 Qiagen Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Qiagen SWOT Analysis
2.11.4 Qiagen Product and Services
2.11.5 Qiagen Cancer Test Revenue, Gross Margin and Market Share (2018-2019)
2.12 Roche(Ventana Medical Systems)
2.12.1 Roche(Ventana Medical Systems) Details
2.12.2 Roche(Ventana Medical Systems) Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Roche(Ventana Medical Systems) SWOT Analysis
2.12.4 Roche(Ventana Medical Systems) Product and Services
2.12.5 Roche(Ventana Medical Systems) Cancer Test Revenue, Gross Margin and Market Share (2018-2019)
2.13 Genomic Health
2.13.1 Genomic Health Details
2.13.2 Genomic Health Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Genomic Health SWOT Analysis
2.13.4 Genomic Health Product and Services
2.13.5 Genomic Health Cancer Test Revenue, Gross Margin and Market Share (2018-2019)
2.14 Vermillion
2.14.1 Vermillion Details
2.14.2 Vermillion Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Vermillion SWOT Analysis
2.14.4 Vermillion Product and Services
2.14.5 Vermillion Cancer Test Revenue, Gross Margin and Market Share (2018-2019)
2.15 Siemens Heathcare Diagnostics
2.15.1 Siemens Heathcare Diagnostics Details
2.15.2 Siemens Heathcare Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Siemens Heathcare Diagnostics SWOT Analysis
2.15.4 Siemens Heathcare Diagnostics Product and Services
2.15.5 Siemens Heathcare Diagnostics Cancer Test Revenue, Gross Margin and Market Share (2018-2019)
2.16 Panacea Pharmaceuticals
2.16.1 Panacea Pharmaceuticals Details
2.16.2 Panacea Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Panacea Pharmaceuticals SWOT Analysis
2.16.4 Panacea Pharmaceuticals Product and Services
2.16.5 Panacea Pharmaceuticals Cancer Test Revenue, Gross Margin and Market Share (2018-2019)
2.17 QIAGEN Marseille (Earlier Ipsogen)
2.17.1 QIAGEN Marseille (Earlier Ipsogen) Details
2.17.2 QIAGEN Marseille (Earlier Ipsogen) Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 QIAGEN Marseille (Earlier Ipsogen) SWOT Analysis
2.17.4 QIAGEN Marseille (Earlier Ipsogen) Product and Services
2.17.5 QIAGEN Marseille (Earlier Ipsogen) Cancer Test Revenue, Gross Margin and Market Share (2018-2019)
2.18 Trovagene
2.18.1 Trovagene Details
2.18.2 Trovagene Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Trovagene SWOT Analysis
2.18.4 Trovagene Product and Services
2.18.3 Trovagene Cancer Test Revenue, Gross Margin and Market Share (2018-2019)
2.19 Roche
2.19.1 Roche Details
2.19.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Roche SWOT Analysis
2.19.4 Roche Product and Services
2.19.5 Roche Cancer Test Revenue, Gross Margin and Market Share (2018-2019)
2.20 Myriad Genetics
2.20.1 Myriad Genetics Details
2.20.2 Myriad Genetics Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Myriad Genetics SWOT Analysis
2.20.4 Myriad Genetics Product and Services
2.20.5 Myriad Genetics Cancer Test Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Cancer Test Market Size by Players (2015-2020)
3.2 China Cancer Test Market Size by Players (2015-2020)
3.3 Market Concentration Rate
3.3.1 Top 5 Cancer Test Players Market Share
3.3.2 Top 10 Cancer Test Players Market Share
4 North America Market Size and Forecast by Countries
4.1 North America Cancer Test Market Size by Countries (2015-2020)
4.2 North America Cancer Test Market Size and Forecast by Countries (2015-2026)
4.3 United States Cancer Test Market Size and Forecast (2015-2025)
4.4 Canada Cancer Test Market Size and Forecast (2015-2025)
4.5 Mexico Cancer Test Market Size and Forecast (2015-2025)
5 Europe Market Size and Forecast by Countries
5.1 Europe Cancer Test Market Size by Countries (2015-2020)
5.2 Europe Cancer Test Market Size and Forecast by Countries (2015-2026)
5.3 Germany Cancer Test Market Size and Forecast (2015-2025)
5.4 France Cancer Test Market Size and Forecast (2015-2025)
5.5 UK Cancer Test Market Size and Forecast (2015-2025)
5.6 Russia Cancer Test Market Size and Forecast (2015-2025)
5.7 Italy Cancer Test Market Size and Forecast (2015-2025)
6 Asia-Pacific Market Size and Forecast by Countries
6.1 Asia-Pacific Cancer Test Market Size by Regions (2015-2020)
6.2 Asia-Pacific Cancer Test Market Size and Forecast by Regions (2015-2026)
6.3 China Cancer Test Market Size and Forecast (2015-2025)
6.4 Japan Cancer Test Market Size and Forecast (2015-2025)
6.5 Korea Cancer Test Market Size and Forecast (2015-2025)
6.6 India Cancer Test Market Size and Forecast (2015-2025)
6.7 Southeast Asia Cancer Test Market Size and Forecast (2015-2025)
7 South America Market Size and Forecast by Countries
7.1 South America Cancer Test Market Size by Countries (2015-2020)
7.2 South America Cancer Test Market Size and Forecast by Countries (2015-2026)
7.3 Brazil Cancer Test Market Size and Forecast (2015-2025)
7.4 Argentina Cancer Test Market Size and Forecast (2015-2025)
8 Middle East & Africa Market Size and Forecast by Countries
8.1 Middle East & Africa Cancer Test Revenue by Regions (2015-2020)
8.2 Middle East & Africa Cancer Test Market Size and Forecast by Countries (2015-2026)
8.3 Saudi Arabia Cancer Test Market Size and Forecast (2015-2025)
8.4 UAE Cancer Test Market Size and Forecast (2015-2025)
8.5 Egypt Cancer Test Market Size and Forecast (2015-2025)
8.6 South Africa Cancer Test Market Size and Forecast (2015-2025)
9 Market Size Segment by Type
9.1 Global Cancer Test Market Size and Forecast by Type (2015-2025)
9.1.1 Global Cancer Test Market Size by Type (2015-2020)
9.1.2 Global Cancer Test Market Size Forecast by Type (2020-2025)
9.2 China Cancer Test Market Size and Forecast by Type (2015-2025)
9.2.1 China Cancer Test Market Size by Type (2015-2020)
9.2.2 China Cancer Test Market Size Forecast by Type (2020-2025)
10 Market Size Segment by Application
10.1 Global Cancer Test Market Size and Forecast by Application (2015-2025)
10.1.1 Global Cancer Test Market Size by Application (2015-2020)
10.1.2 Global Cancer Test Market Size Forecast by Application (2020-2025)
10.2 China Cancer Test Market Size and Forecast by Application (2015-2025)
10.2.1 China Cancer Test Market Size by Application (2015-2020)
10.2.2 China Cancer Test Market Size Forecast by Application (2020-2025)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Data Source
12.3 Disclaimer
12.4 About US
Tables and Figures
List of Tables
Table 1. Global Cancer Test Revenue (USD Million) by Type: 2015 Versus 2019 Versus 2025
Table 2. Breakdown of Cancer Test by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cancer Test Revenue (USD Million) by Application: 2015 Versus 2019 Versus 2025
Table 4. Global Market Cancer Test Market Size (USD Million) Comparison by Regions (2020-2025)
Table 5. Global Cancer Test Revenue (USD Million) by Regions (2015-2020)
Table 6. Global Cancer Test Revenue Share by Regions (2015-2020)
Table 7. Global Cancer Test Revenue (USD Million) by Regions (2020-2025)
Table 8. Global Cancer Test Revenue Market Share by Regions (2020-2025)
Table 9. Abbott Corporate Information, Location and Competitors
Table 10. Abbott Major Business
Table 11. Abbott Cancer Test Total Revenue (USD Million) (2017-2018)
Table 12. Abbott SWOT Analysis
Table 13. Abbott Cancer Test Product and Solutions
Table 14. Abbott Cancer Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 15. CytoCore Corporate Information, Location and Competitors
Table 16. CytoCore Major Business
Table 17. CytoCore Cancer Test Total Revenue (USD Million) (2018-2019)
Table 18. CytoCore SWOT Analysis
Table 19. CytoCore Cancer Test Product and Solutions
Table 20. CytoCore Cancer Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 21. Beckman Coulter Corporate Information, Location and Competitors
Table 22. Beckman Coulter Major Business
Table 23. Beckman Coulter Cancer Test Total Revenue (USD Million) (2017-2018)
Table 24. Beckman Coulter SWOT Analysis
Table 25. Beckman Coulter Cancer Test Product and Solutions
Table 26. Beckman Coulter Cancer Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 27. Radient Pharmaceuticals Corporate Information, Location and Competitors
Table 28. Radient Pharmaceuticals Major Business
Table 29. Radient Pharmaceuticals Cancer Test Total Revenue (USD Million) (2017-2018)
Table 30. Radient Pharmaceuticals SWOT Analysis
Table 31. Radient Pharmaceuticals Cancer Test Product and Solutions
Table 32. Radient Pharmaceuticals Cancer Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 33. Cepheid Corporate Information, Location and Competitors
Table 34. Cepheid Major Business
Table 35. Cepheid Cancer Test Total Revenue (USD Million) (2017-2018)
Table 36. Cepheid SWOT Analysis
Table 37. Cepheid Cancer Test Product and Solutions
Table 38. Cepheid Cancer Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 39. BD Diagnostics Corporate Information, Location and Competitors
Table 40. BD Diagnostics Major Business
Table 41. BD Diagnostics Cancer Test Total Revenue (USD Million) (2017-2018)
Table 42. BD Diagnostics SWOT Analysis
Table 43. BD Diagnostics Cancer Test Product and Solutions
Table 44. BD Diagnostics Cancer Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 45. Gen-Probe Corporate Information, Location and Competitors
Table 46. Gen-Probe Major Business
Table 47. Gen-Probe Cancer Test Total Revenue (USD Million) (2017-2018)
Table 48. Gen-Probe SWOT Analysis
Table 49. Gen-Probe Cancer Test Product and Solutions
Table 50. Gen-Probe Cancer Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 51. bioMerieux Corporate Information, Location and Competitors
Table 52. bioMerieux Major Business
Table 53. bioMerieux Cancer Test Total Revenue (USD Million) (2017-2018)
Table 54. bioMerieux SWOT Analysis
Table 55. bioMerieux Cancer Test Product and Solutions
Table 56. bioMerieux Cancer Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 57. BioCurex Corporate Information, Location and Competitors
Table 58. BioCurex Major Business
Table 59. BioCurex Cancer Test Total Revenue (USD Million) (2017-2018)
Table 60. BioCurex SWOT Analysis
Table 61. BioCurex Cancer Test Product and Solutions
Table 62. BioCurex Cancer Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 63. DiagnoCure Corporate Information, Location and Competitors
Table 64. DiagnoCure Major Business
Table 65. DiagnoCure Cancer Test Total Revenue (USD Million) (2017-2018)
Table 66. DiagnoCure SWOT Analysis
Table 67. DiagnoCure Cancer Test Product and Solutions
Table 68. DiagnoCure Cancer Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 69. Qiagen Corporate Information, Location and Competitors
Table 70. Qiagen Major Business
Table 71. Qiagen Cancer Test Total Revenue (USD Million) (2017-2018)
Table 72. Qiagen SWOT Analysis
Table 73. Qiagen Cancer Test Product and Solutions
Table 74. Qiagen Cancer Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 75. Roche(Ventana Medical Systems) Corporate Information, Location and Competitors
Table 76. Roche(Ventana Medical Systems) Major Business
Table 77. Roche(Ventana Medical Systems) Cancer Test Total Revenue (USD Million) (2017-2018)
Table 78. Roche(Ventana Medical Systems) SWOT Analysis
Table 79. Roche(Ventana Medical Systems) Cancer Test Product and Solutions
Table 80. Roche(Ventana Medical Systems) Cancer Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 81. Genomic Health Corporate Information, Location and Competitors
Table 82. Genomic Health Major Business
Table 83. Genomic Health Cancer Test Total Revenue (USD Million) (2017-2018)
Table 84. Genomic Health SWOT Analysis
Table 85. Genomic Health Cancer Test Product and Solutions
Table 86. Genomic Health Cancer Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 87. Vermillion Corporate Information, Location and Competitors
Table 88. Vermillion Major Business
Table 89. Vermillion Cancer Test Total Revenue (USD Million) (2017-2018)
Table 90. Vermillion SWOT Analysis
Table 91. Vermillion Cancer Test Product and Solutions
Table 92. Vermillion Cancer Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 93. Siemens Heathcare Diagnostics Corporate Information, Location and Competitors
Table 94. Siemens Heathcare Diagnostics Major Business
Table 95. Siemens Heathcare Diagnostics Cancer Test Total Revenue (USD Million) (2017-2018)
Table 96. Siemens Heathcare Diagnostics SWOT Analysis
Table 97. Siemens Heathcare Diagnostics Cancer Test Product and Solutions
Table 98. Siemens Heathcare Diagnostics Cancer Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 99. Panacea Pharmaceuticals Corporate Information, Location and Competitors
Table 100. Panacea Pharmaceuticals Major Business
Table 101. Panacea Pharmaceuticals Cancer Test Total Revenue (USD Million) (2017-2018)
Table 102. Panacea Pharmaceuticals SWOT Analysis
Table 103. Panacea Pharmaceuticals Cancer Test Product and Solutions
Table 104. Panacea Pharmaceuticals Cancer Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 105. QIAGEN Marseille (Earlier Ipsogen) Corporate Information, Location and Competitors
Table 106. QIAGEN Marseille (Earlier Ipsogen) Major Business
Table 107. QIAGEN Marseille (Earlier Ipsogen) Cancer Test Total Revenue (USD Million) (2017-2018)
Table 108. QIAGEN Marseille (Earlier Ipsogen) SWOT Analysis
Table 109. QIAGEN Marseille (Earlier Ipsogen) Cancer Test Product and Solutions
Table 110. QIAGEN Marseille (Earlier Ipsogen) Cancer Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 111. Trovagene Cancer Test Type and Application
Table 112. Trovagene Major Business
Table 113. Trovagene Cancer Test Total Revenue (USD Million) (2017-2018)
Table 114. Trovagene SWOT Analysis
Table 115. Trovagene Cancer Test Product and Solutions
Table 116. Trovagene Cancer Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 117. Roche Corporate Information, Location and Competitors
Table 118. Roche Major Business
Table 119. Roche Cancer Test Total Revenue (USD Million) (2017-2018)
Table 120. Roche SWOT Analysis
Table 121. Roche Cancer Test Product and Solutions
Table 122. Roche Cancer Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 123. Myriad Genetics Corporate Information, Location and Competitors
Table 124. Myriad Genetics Major Business
Table 125. Myriad Genetics Cancer Test Total Revenue (USD Million) (2017-2018)
Table 126. Myriad Genetics SWOT Analysis
Table 127. Myriad Genetics Cancer Test Product and Solutions
Table 128. Myriad Genetics Cancer Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 129. Global Cancer Test Revenue (USD Million) by Players (2015-2020)
Table 130. Global Cancer Test Revenue Share by Players (2015-2020)
Table 131. Key Players Cancer Test Revenue (USD Million) in China (2015-2020)
Table 132. Key Players Cancer Test Revenue Share in China (2015-2020)
Table 133. North America Cancer Test Revenue (USD Million) by Countries (2015-2020)
Table 134. North America Cancer Test Revenue Market Share by Countries (2015-2020)
Table 135. North America Cancer Test Revenue (USD Million) by Countries (2020-2026)
Table 136. North America Cancer Test Revenue Market Share by Countries (2020-2026)
Table 137. Europe Cancer Test Revenue (USD Million) by Countries (2015-2020)
Table 138. Europe Cancer Test Revenue Market Share by Countries (2015-2020)
Table 139. Europe Cancer Test Revenue (USD Million) by Countries (2020-2026)
Table 140. Europe Cancer Test Revenue Market Share by Countries (2020-2026)
Table 141. Asia-Pacific Cancer Test Revenue (USD Million) by Countries (2015-2020)
Table 142. Asia-Pacific Cancer Test Revenue Market Share by Countries (2015-2020)
Table 143. Asia-Pacific Cancer Test Revenue (USD Million) by Countries (2020-2026)
Table 144. Asia-Pacific Cancer Test Revenue Market Share by Countries (2020-2026)
Table 145. South America Cancer Test Revenue (USD Million) by Countries (2015-2020)
Table 146. South America Cancer Test Revenue Market Share by Countries (2015-2020)
Table 147. South America Cancer Test Revenue (USD Million) by Countries (2020-2026)
Table 148. South America Cancer Test Revenue Market Share by Countries (2020-2026)
Table 149. Middle East & Africa Cancer Test Revenue (USD Million) by Countries (2015-2020)
Table 150. Middle East & Africa Cancer Test Revenue Market Share by Countries (2015-2020)
Table 151. Middle East & Africa Cancer Test Revenue (USD Million) by Countries (2020-2026)
Table 152. Middle East & Africa Cancer Test Revenue Market Share by Countries (2020-2026)
Table 153. Global Cancer Test Revenue (USD Million) by Type (2015-2020)
Table 154. Global Cancer Test Revenue Share by Type (2015-2020)
Table 155. Global Cancer Test Revenue Forecast by Type (2020-2025)
Table 156. Global Cancer Test Market Share Forecast by Type (2020-2025)
Table 157. China Cancer Test Revenue (USD Million) by Type (2015-2020)
Table 158. China Cancer Test Revenue Share by Type (2015-2020)
Table 159. China Cancer Test Revenue Forecast by Type (2020-2025)
Table 160. China Cancer Test Market Share Forecast by Type (2020-2025)
Table 161. Global Cancer Test Revenue (USD Million) by Application (2015-2020)
Table 162. Global Cancer Test Revenue Share by Application (2015-2020)
Table 163. Global Cancer Test Revenue Forecast by Application (2020-2025)
Table 164. Global Cancer Test Market Share Forecast by Application (2020-2025)
Table 165. China Cancer Test Revenue (USD Million) by Application (2015-2020)
Table 166. China Cancer Test Revenue Share by Application (2015-2020)
Table 167. China Cancer Test Revenue Forecast by Application (2020-2025)
Table 168. China Cancer Test Market Share Forecast by Application (2020-2025)
List of Figures
Figure 1. Cancer Test Picture
Figure 2. Global Cancer Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. Global Cancer Test Revenue Market Share by Type in 2019
Figure 4. Laboratory Tests Picture
Figure 5. Genetic Tests Picture
Figure 6. Imaging Picture
Figure 7. Endoscopy Picture
Figure 8. Cancer Test Revenue Market Share by Application in 2019
Figure 9. Bladder Cancer Test Picture
Figure 10. Breast Cancer Test Picture
Figure 11. Cervical Cancer Test Picture
Figure 12. Colorectal (Colon) Cancer Test Picture
Figure 13. Ovarian Cancer Test Picture
Figure 14. Prostate Cancer Test Picture
Figure 15. Liver Cancer Test Picture
Figure 16. Flow Cytometry Picture
Figure 17. Other Organ Specific Cancer Test Picture
Figure 18. Global Cancer Test Revenue and Growth Rate (2015-2025) (USD Million)
Figure 19. Global Cancer Test Market Size Share by Regions (2015-2025)
Figure 20. Global Cancer Test Market Size Share by Regions in 2019
Figure 21. Global Cancer Test Revenue Market Share by Regions (2020-2025)
Figure 22. North America Cancer Test Revenue (USD Million) and Growth Rate (2015-2025)
Figure 23. Europe Cancer Test Revenue (USD Million) and Growth Rate (2015-2025)
Figure 24. Asia-Pacific Cancer Test Revenue (USD Million) and Growth Rate (2015-2025)
Figure 25. South America Cancer Test Revenue (USD Million) and Growth Rate (2015-2025)
Figure 26. Middle East & Africa Cancer Test Revenue (USD Million) and Growth Rate (2015-2025)
Figure 27. Global Cancer Test Revenue Share by Players in 2019
Figure 28. Global Top 5 Players Cancer Test Revenue Market Share in 2019
Figure 29. Top 10 Players Cancer Test Revenue Market Share in Global Market in 2019
Figure 30. Global Cancer Test Market Size (USD Million) by Type (2015-2025)
Figure 31. Global Cancer Test Market Size Share by Application (2015-2025)
Figure 32. North America Cancer Test Market Size Share by Countries (2015-2025)
Figure 33. North America Cancer Test Market Size Share by Countries in 2019
Figure 34. United States Cancer Test Market Size (USD Million) and Forecast (2015-2025)
Figure 35. Canada Cancer Test Market Size (USD Million) and Forecast (2015-2025)
Figure 36. Mexico Cancer Test Market Size (USD Million) and Forecast (2015-2025)
Figure 37. Europe Cancer Test Market Size Share by Countries (2015-2025)
Figure 38. Europe Cancer Test Market Size Share by Countries in 2019
Figure 39. Germany Cancer Test Market Size (USD Million) and Forecast (2015-2025)
Figure 40. France Cancer Test Market Size (USD Million) and Forecast (2015-2025)
Figure 41. Russia Cancer Test Market Size (USD Million) and Forecast (2015-2025)
Figure 42. Italy Cancer Test Market Size (USD Million) and Forecast (2015-2025)
Figure 43. Spain Cancer Test Market Size (USD Million) and Forecast (2015-2025)
Figure 44. UK Cancer Test Market Size (USD Million) and Forecast (2015-2025)
Figure 45. Asia Cancer Test Market Size Share by Countries (2015-2025)
Figure 46. Asia Cancer Test Market Size Share by Countries in 2019
Figure 47. China Cancer Test Market Size (USD Million) and Forecast (2015-2025)
Figure 48. Japan Cancer Test Market Size (USD Million) and Forecast (2015-2025)
Figure 49. Korea Cancer Test Market Size (USD Million) and Forecast (2015-2025)
Figure 50. India Cancer Test Market Size (USD Million) and Forecast (2015-2025)
Figure 51. Southeast Asia Cancer Test Market Size (USD Million) and Forecast (2015-2025)
Figure 52. South America Cancer Test Market Size Share by Countries (2015-2025)
Figure 53. South America Cancer Test Market Size Share by Countries in 2019
Figure 54. Brazil Cancer Test Market Size (USD Million) and Forecast (2015-2025)
Figure 55. Argentina Cancer Test Market Size (USD Million) and Forecast (2015-2025)
Figure 56. Middle East & Africa Cancer Test Market Size Share by Countries (2015-2025)
Figure 57. Middle East & Africa Cancer Test Market Size Share by Countries in 2019
Figure 58. Saudi Arabia Cancer Test Market Size (USD Million) and Forecast (2015-2025)
Figure 59. UAE Cancer Test Market Size (USD Million) and Forecast (2015-2025)
Figure 60. Egypt Cancer Test Market Size (USD Million) and Forecast (2015-2025)
Figure 61. South Africa Cancer Test Market Size (USD Million) and Forecast (2015-2025)
Figure 62. Global Cancer Test Revenue Share by Type (2015-2020)
Figure 63. China Cancer Test Revenue Share by Type (2015-2020)
Figure 64. Global Cancer Test Revenue Share by Application (2015-2020)
Figure 65. China Cancer Test Revenue Share by Application (2015-2020)
Companies Mentioned
Abbott
CytoCore
Beckman Coulter
Radient Pharmaceuticals
Cepheid
BD Diagnostics
Gen-Probe
bioMerieux
BioCurex
DiagnoCure
Qiagen
Roche(Ventana Medical Systems)
Genomic Health
Vermillion
Siemens Heathcare Diagnostics
Panacea Pharmaceuticals
QIAGEN Marseille (Earlier Ipsogen)
Trovagene
Roche
Myriad Genetics
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets